Adherence to aspirin in the prevention of pregnancy complications: a systematic review.

IF 2.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY
Jeske M Bij de Weg, Christianne J M de Groot, Johanna I P de Vries, Marjon A de Boer
{"title":"Adherence to aspirin in the prevention of pregnancy complications: a systematic review.","authors":"Jeske M Bij de Weg, Christianne J M de Groot, Johanna I P de Vries, Marjon A de Boer","doi":"10.1016/j.preghy.2025.101244","DOIUrl":null,"url":null,"abstract":"<p><p>The risk-reducing effect of aspirin on pregnancy complications is suggested to depend on therapy adherence. To gain more insight, we reviewed the available literature on aspirin adherence in pregnancy. Three parameters were investigated: methods of assessment of aspirin adherence, definitions of aspirin adherence, and association between aspirin adherence and pregnancy complications. RCTs investigating the preventive effect of aspirin on pregnancy complications including aspirin adherence were included. An update search of the Cochrane review of Duley 2019 was performed, two trial registries were searched and forward citation chasing was performed on May 31, 2025. Risk of bias was assessed according to the criteria of Higgins, checking for selection, performance, detection, attrition, reporting and other bias. Data were summarized and tabulated, resulting in descriptive analyses. Due to the heterogeneity of the data, no meta-analysis could be performed. Adherence of aspirin use during pregnancy was tested with clearly described method(s) and results in 16/63 RCTs on the use of aspirin in pregnancy. From the applied methods, pill count was most frequently performed (n = 14), followed by interview (n = 9) and thromboxane B<sub>2</sub> (TxB<sub>2</sub>) measurements (n = 2). Most studies used a multi-measure approach. Definitions of good adherence were provided in 11 studies: percentage tablet intake (n = 10) with thresholds between ≥50 % to ≥90 %, and/or drop of ≥50 % in serum TxB<sub>2</sub> (n = 2). Most common pill count threshold ≥80 % (n = 6) showed mean adherence of 79.5 %. An association between good adherence and lower incidence of PE was found in 2 studies. Limitations of the systematic review were the lack of a general definition of aspirin adherence and the large heterogeneity in methods, therefore being unable to perform a meta-analysis or draw hard conclusions. In conclusion, 25 % of the RCTs on aspirin in pregnancy investigated aspirin adherence including clearly described method(s) and results and in only 11 a definition on aspirin adherence was set. Multi-measure approach is recommended as test method. Future studies should focus on threshold of good aspirin adherence in pregnancy and dose-response effect.</p>","PeriodicalId":48697,"journal":{"name":"Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health","volume":"41 ","pages":"101244"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.preghy.2025.101244","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The risk-reducing effect of aspirin on pregnancy complications is suggested to depend on therapy adherence. To gain more insight, we reviewed the available literature on aspirin adherence in pregnancy. Three parameters were investigated: methods of assessment of aspirin adherence, definitions of aspirin adherence, and association between aspirin adherence and pregnancy complications. RCTs investigating the preventive effect of aspirin on pregnancy complications including aspirin adherence were included. An update search of the Cochrane review of Duley 2019 was performed, two trial registries were searched and forward citation chasing was performed on May 31, 2025. Risk of bias was assessed according to the criteria of Higgins, checking for selection, performance, detection, attrition, reporting and other bias. Data were summarized and tabulated, resulting in descriptive analyses. Due to the heterogeneity of the data, no meta-analysis could be performed. Adherence of aspirin use during pregnancy was tested with clearly described method(s) and results in 16/63 RCTs on the use of aspirin in pregnancy. From the applied methods, pill count was most frequently performed (n = 14), followed by interview (n = 9) and thromboxane B2 (TxB2) measurements (n = 2). Most studies used a multi-measure approach. Definitions of good adherence were provided in 11 studies: percentage tablet intake (n = 10) with thresholds between ≥50 % to ≥90 %, and/or drop of ≥50 % in serum TxB2 (n = 2). Most common pill count threshold ≥80 % (n = 6) showed mean adherence of 79.5 %. An association between good adherence and lower incidence of PE was found in 2 studies. Limitations of the systematic review were the lack of a general definition of aspirin adherence and the large heterogeneity in methods, therefore being unable to perform a meta-analysis or draw hard conclusions. In conclusion, 25 % of the RCTs on aspirin in pregnancy investigated aspirin adherence including clearly described method(s) and results and in only 11 a definition on aspirin adherence was set. Multi-measure approach is recommended as test method. Future studies should focus on threshold of good aspirin adherence in pregnancy and dose-response effect.

坚持服用阿司匹林预防妊娠并发症:系统综述。
阿司匹林对妊娠并发症的风险降低作用取决于治疗依从性。为了获得更多的见解,我们回顾了有关妊娠期阿司匹林依从性的现有文献。研究了三个参数:阿司匹林依从性的评估方法,阿司匹林依从性的定义,阿司匹林依从性与妊娠并发症的关系。研究阿司匹林对妊娠并发症的预防作用的随机对照试验包括阿司匹林的依从性。对Duley 2019的Cochrane综述进行了更新检索,检索了两个试验注册库,并于2025年5月31日进行了引文追踪。根据Higgins标准评估偏倚风险,检查选择、表现、检测、减员、报告等偏倚。对数据进行汇总和制表,得出描述性分析。由于数据的异质性,无法进行meta分析。在16/63个关于妊娠期阿司匹林使用的随机对照试验中,用明确描述的方法和结果测试了妊娠期阿司匹林使用的依从性。从应用的方法来看,最常见的是药片计数(n = 14),其次是访谈(n = 9)和血栓素B2 (TxB2)测量(n = 2)。大多数研究使用了多测量方法。11项研究提供了良好依从性的定义:片剂摄入量百分比(n = 10),阈值在≥50%至≥90%之间,和/或血清TxB2下降≥50% (n = 2)。最常见的药丸计数阈值≥80% (n = 6)显示平均依从性为79.5%。2项研究发现良好的依从性与较低的PE发生率之间存在关联。系统评价的局限性是缺乏阿司匹林依从性的一般定义和方法的大异质性,因此无法进行荟萃分析或得出确凿的结论。总之,25%的关于妊娠期阿司匹林的随机对照试验调查了阿司匹林的依从性,包括明确描述的方法和结果,只有11项试验对阿司匹林的依从性进行了定义。建议采用多测量法作为测试方法。未来的研究应关注妊娠期阿司匹林良好依从性的阈值和剂量-反应效应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health OBSTETRICS & GYNECOLOGYPERIPHERAL VASCULAR-PERIPHERAL VASCULAR DISEASE
CiteScore
4.90
自引率
0.00%
发文量
127
期刊介绍: Pregnancy Hypertension: An International Journal of Women''s Cardiovascular Health aims to stimulate research in the field of hypertension in pregnancy, disseminate the useful results of such research, and advance education in the field. We publish articles pertaining to human and animal blood pressure during gestation, hypertension during gestation including physiology of circulatory control, pathophysiology, methodology, therapy or any other material relevant to the relationship between elevated blood pressure and pregnancy. The subtitle reflects the wider aspects of studying hypertension in pregnancy thus we also publish articles on in utero programming, nutrition, long term effects of hypertension in pregnancy on cardiovascular health and other research that helps our understanding of the etiology or consequences of hypertension in pregnancy. Case reports are not published unless of exceptional/outstanding importance to the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信